Northeast Pharmaceutical Group Co., Ltd.

符号: 000597.SZ

SHZ

4.66

CNY

今天的市场价格

19.6168
市盈率
-0.2211
PEG比率
6.66B
MRK市值
0.02%
DIV收益率

Northeast Pharmaceutical Group Co., Ltd. (000597-SZ) 财务报表

Q: 什么是 Northeast Pharmaceutical Group Co., Ltd. (000597.SZ) 总资产是多少？

Northeast Pharmaceutical Group Co., Ltd. (000597.SZ) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Northeast Pharmaceutical Group Co., Ltd. (000597.SZ). 的默认数据。公司收入显示 3690.249 M 的平均值，即 0.094 % 增长率。整个期间的平均毛利润为 1204.887 M，即 0.121 %. 平均毛利率为 0.279 %. 公司去年的净收入增长率为 0.023 %，等于 -0.622 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Northeast Pharmaceutical Group Co., Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.106. 在流动资产领域，000597.SZ 的报告货币为9783.06. 这些资产中的很大一部分，即 5651.183 是现金和短期投资。与去年的数据相比，该部分的变化率为0.470%. 公司的长期投资虽然不是其重点，但以报告货币计算的0（如果有的话）为0。这表明与上一报告期相比，100.000% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 352.8. 这一数字表明，2.096% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 4988.27. 这方面的年同比变化率为 0.094%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为2616.561，存货估值为 1364.09，商誉估值为 26.12（如有. 无形资产总额（如果有）按 824.5 估值. 应付账款和短期债务分别为 1398.1 和 6527.42. 债务总额为6911.5，债务净额为 1260.32. 其他流动负债为 1511.8，加上总负债 9957.79. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	20024.02	5651.2	3844.9	2550.4	1481.3	1525.4	1283.6	1709.8	1773.4	1706.5	1766	1539	852.3	798.1	1057	1764	768	319.4	214	374.2	467.6	359.6	336.5	220.8	213.9	226.8	152.4	150.7	236.4	130.2	118.6	28.6
balance-sheet.row.short-term-investments	0	0	0	0	0	0	-1.6	-1.8	-0.9	-1.9	-3.1	-4.2	-5	-5.8	0	-59	0	0	0	3.1	3.3	0	0	0	0	65.5	65.5	65.5	105.5	0	0	3.7
balance-sheet.row.net-receivables	11582.19	2616.6	2840.9	2956.8	2777.5	3015.9	2973.2	2469.6	1774.9	1309.9	1337.5	1092	960	976.1	1159.8	1170.5	1112.6	1306.6	882.5	973.1	850.4	997.9	1170.3	1475.2	95.7	87.7	160.1	58.5	51.2	34.1	58.3	32
balance-sheet.row.inventory	5402.13	1364.1	1220.4	1247.3	1253.2	1283.8	1271.2	1352.9	1092.4	861.5	978.1	1067.9	841.5	875.2	762.6	659.7	673.1	587.1	434.7	387.5	421.8	405.1	398.9	349.7	210.7	212.2	207.9	191.5	315.3	280.3	248.2	198.8
balance-sheet.row.other-current-assets	352.48	151.2	24.3	44.9	41.2	54.3	65.3	38.4	399.1	20.2	55	6.7	0.1	0	-51.3	-49.2	0.1	-221.1	8.6	-144	0.5	0.5	0.8	1	1406.5	1267.8	1252.8	955.9	762	652.4	536.4	544.6
balance-sheet.row.total-current-assets	37360.81	9783.1	7930.5	6799.3	5553.2	5879.4	5593.3	5570.7	5040	3898.1	4136.6	3705.6	2653.9	2649.4	2928.1	3545	2553.9	1991.9	1539.8	1590.7	1740.4	1763	1906.5	2046.7	1926.8	1794.4	1773.2	1356.7	1364.9	1096.9	961.5	804
balance-sheet.row.property-plant-equipment-net	18042.19	4511.2	4852.5	5226.4	5488.5	5421.2	4781.8	3792.1	3721.1	3816.5	3412.1	2793.6	2306.2	2117.5	1786.5	1657.7	1143.9	748.2	545	588.6	558.6	588.2	585.3	515.9	524.4	581	577.6	561.5	1230.4	1001.6	538.7	629
balance-sheet.row.goodwill	104.47	26.1	26.1	26.1	26.1	26.1	26.1	36.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	3305.87	824.5	828.6	952	943.6	920.1	854	914.4	868.2	844.2	802.3	790.2	830.3	878.7	856.3	837.8	354.4	233.1	106.7	100.5	112.6	144.2	164.9	165.6	170.4	156.5	159.2	132.3	136	139.4	42.3	37
balance-sheet.row.goodwill-and-intangible-assets	3410.34	850.6	854.7	978.1	969.7	946.2	880.1	951.4	868.2	844.2	802.3	790.2	830.3	878.7	856.3	837.8	354.4	233.1	106.7	100.5	112.6	144.2	164.9	165.6	170.4	156.5	159.2	132.3	136	139.4	42.3	37
balance-sheet.row.long-term-investments	1.41	0	0	2.2	2.4	2.1	3.2	3.4	2.5	3.5	4.7	5.8	6.6	9.4	0	65.4	0	0	0	13.2	16.3	0	0	0	0	10	9.8	-64.9	69.6	0	0	0
balance-sheet.row.tax-assets	486.64	128.1	109.2	102.1	89	90.5	86.8	66.3	51.2	45.3	32.6	41.3	24.5	39	27.3	32	43.5	70	0	0	0	0	0	0	0	-6.9	68.9	65.5	105.5	0	0	0
balance-sheet.row.other-non-current-assets	123.57	0.7	63.4	71.3	62.9	200.5	373.5	209.1	107	85	184.6	218.1	171.9	178.5	7.4	-59	8.2	8.1	16.1	4.8	6.4	26.3	24.4	27.8	47.6	66.4	1.5	114.8	190.7	214.3	55.6	33.5
balance-sheet.row.total-non-current-assets	22064.14	5490.6	5879.8	6380.2	6612.5	6660.5	6125.4	5022.3	4750	4794.5	4436.2	3849	3339.4	3223.1	2677.6	2534	1550.1	1059.4	667.7	707.1	694	758.7	774.5	709.3	742.4	806.9	816.9	809.2	1732.3	1355.3	636.6	699.5
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	59424.95	15273.7	13810.3	13179.5	12165.7	12539.8	11718.7	10593	9790	8692.6	8572.9	7554.6	5993.3	5872.5	5605.7	6078.9	4104	3051.3	2207.5	2297.9	2434.3	2521.7	2681	2756	2669.2	2601.4	2590.1	2165.9	3097.2	2452.2	1598.1	1503.5
balance-sheet.row.account-payables	12329.58	1398.1	4320.5	3695.8	2763.9	2695.7	2522.6	1634.3	1609.9	984.8	856.1	783.2	768	695.9	674.7	680.1	592.5	480.4	356.3	435.8	421.2	521.2	372.8	360.3	273.8	304	356.2	249.2	278	232.3	141	143.3
balance-sheet.row.short-term-debt	17072.17	6527.4	1976.8	3179.8	3309.5	3784.5	3045.6	3583.5	2812.6	3239.7	2992	3106.5	2288.1	2030.3	1067.2	1615.9	1563.4	1371.9	536.8	525.3	623.1	729.3	1044.8	1042.5	1024.8	810.3	675.7	560.8	894.8	733.4	548.8	495.4
balance-sheet.row.tax-payables	300.92	55.6	155.6	65.2	85.7	78.3	63	60.3	45.3	23.9	26.5	31.3	13	-18.4	-89.3	50.6	62.4	35.8	38.7	18.4	42.9	15.2	15.9	28.5	34.2	38.1	34.7	23.5	16.3	17	19.8	22.9
balance-sheet.row.long-term-debt-total	1575.12	352.8	255.9	218	200	150	874.3	235	600	543	100	100	608.6	609.4	1162.8	1011.3	6	55	70	143.7	171	141	45.7	90.8	51.7	265.5	275.6	306.3	663.6	540	178.3	189.2
Deferred Revenue Non Current	641.17	157.1	174.7	194	213.3	223.5	215.6	245.9	249	237	241	211.8	0	301.2	332.5	332.5	59.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	18.94	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	3236.7	1511.8	1933.1	11	11.9	112.8	1020.3	105.7	91.2	74.4	219.8	81.8	71.3	85.3	76.5	70	72.9	54.3	52.4	59.4	61.4	31.9	55.3	63.1	27.7	0.7	0.5	0.5	2.5	1	0.2	35.1
balance-sheet.row.total-non-current-liabilities	2571.93	389.3	673.9	690.6	727.3	722.8	1474.5	2005.2	2422.5	1660.6	1399.8	1463.9	826.5	1103.1	1606.2	1378.2	86	85.1	91.1	155.7	199.9	147.8	49.6	97.5	83.1	269	268.3	305.7	665.7	543.8	178.3	189.2
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	114.15	31.3	17.9	18	56.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	39075.25	9957.8	9097.1	8889.2	8043.5	8622	8125.9	8045	7356	6291.6	5811.7	5955.5	4243	4129.6	3540.2	4025.3	2529.4	2162.1	1280	1397.8	1550.3	1651.5	1807.7	1872.6	1763.7	1731.6	1591	1230.5	2102.6	1677.1	1110.9	1052.4
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	5726.84	1429.1	1434.3	1347.9	1350.7	904.7	569.6	474.7	474.7	474.7	474.7	333.8	333.8	333.8	333.8	333.8	333.8	303.8	303.8	303.8	303.8	303.8	303.8	303.8	303.8	303.8	253.2	194.8	194.8	149.8	149.8	149.8
balance-sheet.row.retained-earnings	3762.51	1013.4	805.2	496.1	416.1	403.8	253.8	79.8	-39.1	-62.9	321.4	234.3	401.3	393.6	783.5	770.2	369.2	69.1	1.5	-14.7	-13.8	-8	-16.3	-4.2	11.1	-117.5	51.1	0	18	89.2	49.2	44
balance-sheet.row.accumulated-other-comprehensive-income-loss	6516.79	462.4	296.9	425.2	446.9	406.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	3512.39	2083.4	2022.9	1874.6	1766.9	2096	2647.3	1879.1	1879	1877.5	1868.2	935.3	930.1	929.8	906	915.2	868.6	514.4	622.2	611	594	574.5	585.7	584.2	590.5	683.3	694.6	740.6	781.9	536.1	288.2	257.3
balance-sheet.row.total-stockholders-equity	19518.53	4988.3	4559.3	4143.7	3980.6	3810.8	3470.8	2433.6	2314.5	2289.2	2664.3	1503.4	1665.2	1657.1	2023.3	2019.2	1571.5	887.4	927.5	900.1	884	870.3	873.3	883.8	905.4	869.5	998.9	935.4	994.6	775.1	487.1	451.1
balance-sheet.row.total-liabilities-and-stockholders-equity	59424.95	15273.7	13810.3	13179.5	12165.7	12539.8	11718.7	10593	9790	8692.6	8572.9	7554.6	5993.3	5872.5	5605.7	6078.9	4104	3051.3	2207.5	2297.9	2434.3	2521.7	2681	2756.5	2669.2	2601.4	2590.1	2165.9	3097.2	2452.2	1598.1	1503.5
balance-sheet.row.minority-interest	674.05	170.5	153.9	146.5	141.6	107	122.1	114.4	119.5	111.8	96.9	95.6	85.1	85.7	42.1	34.4	3	1.8	0	0	0	0	0	0.1	0.2	0.2	0.2	0	0	0	0	0
balance-sheet.row.total-equity	20192.58	5158.7	4713.3	4290.3	4122.2	3917.8	3592.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	59424.95	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	1.41	0	0	2.2	2.4	2.1	1.6	1.6	1.6	1.6	1.6	1.6	1.6	3.7	4.6	6.4	8.2	8.1	15.1	16.3	19.6	21.8	22.4	25	53	75.5	75.3	0.6	175.1	0	0	3.7
balance-sheet.row.total-debt	18700.31	6911.5	2232.7	3397.8	3509.5	3934.5	3045.6	3818.5	3412.6	3782.7	3092	3206.5	2896.7	2639.7	2230	2627.2	1569.4	1426.9	606.8	669	794.1	870.3	1090.4	1133.3	1076.5	1075.9	951.3	867.1	1558.3	1273.5	727.1	684.6
balance-sheet.row.net-debt	-1323.7	1260.3	-1612.2	847.4	2028.3	2409.1	1762	2108.7	1639.2	2076.2	1326	1667.4	2044.4	1841.6	1173	863.1	801.4	1107.5	392.8	297.9	329.8	510.7	753.9	912.5	862.6	914.6	864.4	781.9	1427.4	1143.3	608.5	659.6

现金流量表

在 Northeast Pharmaceutical Group Co., Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.594 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了-0.363 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-227964763.000. 与上一年相比， -0.111 发生了变化. 在同一时期，公司记录了 575.08, 0 和 -1749.6，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-142.91 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -1183.06，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	346.04	358.5	357	95.4	10.8	170.4	201.4	92.1	26.3	-392.2	83.8	-165.2	12.2	-383.2	57.3	476.1	357.9	47	19.6	13.4	8.1	8.7	10.2	10.1	28.8	43.4	68.3
cash-flows.row.depreciation-and-amortization	-4.3	575.1	561.1	550.9	480.8	340.4	323	326.3	317.3	213	171.3	147.7	158.9	217.8	190.2	128	105.3	101.7	80.2	85.6	62.4	66.5	51.1	44.1	36.3	36.2	42.5
cash-flows.row.deferred-income-tax	-354.72	-18.9	-7.2	-13.2	1.3	-0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	102.23	-1899.7	79.8	-1.2	52.4	156.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	100.67	-647	254	-113.6	-172.6	-582.4	-656.8	-952.2	-125	64.7	-256.8	-375.6	96.5	-200.7	-15.3	-56.7	-43.8	-168.5	-267.7	-54.3	67	97.2	66.8	-50.6	-116.1	-122.8	-167.2
cash-flows.row.account-receivables	149.06	149.1	115	-268.9	249.2	-79.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-150.94	-150.9	-5.6	8.3	-35.4	-105.7	49.3	-232.1	-236.1	96.5	22.4	-200.2	26.1	-143.5	-101.7	15.3	-79.4	-149.4	-45.9	29.3	-42.6	-13.2	-50.5	-130.6	1.5	0.3	-7.6
cash-flows.row.account-payables	0	-747.7	151.8	160.3	-387.8	-396.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	102.54	102.5	-7.2	-13.2	1.3	-0.9	-706.1	-720.2	111	-31.8	-279.2	-175.4	70.3	-57.2	86.4	-72	35.6	-19.1	-221.8	-83.6	109.6	110.5	117.3	80	-117.6	-123.1	-159.6
cash-flows.row.other-non-cash-items	377.38	2218.9	-136.1	228.2	198.2	268.1	417.6	232.6	165.8	214.2	48.7	126.7	-181.5	132.8	23.8	68.5	289.6	218.3	61.9	66.8	73.5	57.6	29.3	75.2	87.1	97.9	48.8
cash-flows.row.net-cash-provided-by-operating-activities	567.29	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-249.37	-235.4	-244.1	-119.8	-400.4	-229.2	-565.7	-414.6	-177	-346	-532.3	-452	-178.9	-421.7	-473.9	-862.8	-359.3	-87.8	-47.8	-103.7	-61.1	-87.5	-38.1	-46.6	-12.2	-9.4	-21.4
cash-flows.row.acquisitions-net	0.42	7.5	3.2	7.8	77.7	-4	0.1	-23.1	186.2	325.3	0	-1	0	54.8	0	10.1	1.5	0	0	127.4	8.3	0	5.8	50.2	12.4	9.4	0.1
cash-flows.row.purchases-of-investments	0	0	0	-500	0	0	0	-16	-1667.9	-325	0	-0.3	0	0.4	0	8.3	3.8	0	0	-0.9	-41.5	0	-0.3	-1.3	-0.5	-16.2	-12.2
cash-flows.row.sales-maturities-of-investments	0	0	0	15.9	0	0	0	399.5	1300.7	2.4	1.3	454.7	1.5	1.4	0	0.3	0.4	0.3	4.6	14.8	0.7	1.4	16.9	5.6	57.4	1.7	61.3
cash-flows.row.other-investing-activites	0.42	0	-15.4	496	0	1.1	2.6	2.6	-177	-40.3	58.1	-452	3	72.4	141.5	324.2	38.3	22.1	3.7	-103.7	14.1	8.4	0	-46.6	-12.2	-9.4	5.3
cash-flows.row.net-cash-used-for-investing-activites	-248.95	-228	-256.3	-100.1	-322.7	-232.1	-563	-51.7	-535	-383.7	-472.9	-450.6	-174.3	-292.5	-332.4	-519.8	-315.3	-65.5	-39.5	-66	-79.5	-77.6	-15.7	-38.6	44.9	-23.9	33.2
cash-flows.row.debt-repayment	-3639	-1749.6	-3355.7	-4061.6	-4091.2	-4217.8	-5427.7	-2919.6	-4217.5	-3674.5	-4058.8	-2648.1	-2200.9	-1153.8	-2055.4	-2314.5	-1873.3	-1324.1	-361.7	-560.7	-651.4	-1322.3	-1056.2	-1192.6	-816.9	-242	-141.3
cash-flows.row.common-stock-issued	0	0	0	7.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-14.22	-14.2	0	-7.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-235.2	-142.9	-109.5	-165.5	-125	-135.6	-166.6	-159.3	-156.4	-184.2	-199.6	-189.9	-175.4	-142	-163.6	-123.1	-129	-67.9	-17.2	-25.9	-54	-66.5	-64.7	-66.6	-62.3	-82.8	-78.3
cash-flows.row.other-financing-activites	943.99	-1183.1	3406.1	4094.7	3856.9	4248.5	5449	3196.7	4465	4029.9	4915.2	4263.5	2462	1588.8	1671	3329.6	1859.6	1359	367.2	454	678.6	1259.4	1094.9	1245.6	853.9	368.4	195.7
cash-flows.row.net-cash-used-provided-by-financing-activities	254.79	381.1	-59	-132.4	-359.3	-104.9	-145.2	117.8	91.1	171.1	656.7	1425.5	85.7	293	-548	892	-142.7	-33	-11.7	-132.6	-26.8	-129.4	-25.9	-13.6	-25.3	43.6	-23.9
cash-flows.row.effect-of-forex-changes-on-cash	10.09	6.3	6.9	-1.7	-1.6	0.6	0.6	-6	2.5	0.6	0	-0.2	0	0	-0.1	0	0	0	0	0	0.2	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	1727.72	1806.3	800.2	512.4	-112.7	16.2	-422.6	-241.1	-56.9	-112.3	230.8	708.3	-2.5	-232.9	-624.6	988.1	251	100.1	-157.1	-87.2	105	23.1	115.7	26.6	55.7	74.4	1.7
cash-flows.row.cash-at-end-of-period	16470	5651.2	2020.8	1220.6	708.3	820.9	804.7	1227.3	1468.4	1525.3	1637.6	1406.8	698.5	701	933.9	1558.5	570.4	319.4	214	371.1	464.3	359.6	336.5	220.8	213.9	161.3	86.9
cash-flows.row.cash-at-beginning-of-period	14742.27	3844.9	1220.6	708.3	820.9	804.7	1227.3	1468.4	1525.3	1637.6	1406.8	698.5	701	933.9	1558.5	570.4	319.4	219.3	371.1	458.3	359.4	336.5	220.8	194.2	158.3	86.9	85.2
cash-flows.row.operating-cash-flow	567.29	586.8	1108.6	746.5	570.9	352.6	285.1	-301.2	384.5	99.7	47	-266.4	86.1	-233.3	256	615.9	709	198.6	-106	111.4	211.1	230.1	157.4	78.8	36.1	54.6	-7.6
cash-flows.row.capital-expenditure	-249.37	-235.4	-244.1	-119.8	-400.4	-229.2	-565.7	-414.6	-177	-346	-532.3	-452	-178.9	-421.7	-473.9	-862.8	-359.3	-87.8	-47.8	-103.7	-61.1	-87.5	-38.1	-46.6	-12.2	-9.4	-21.4
cash-flows.row.free-cash-flow	317.92	351.3	864.4	626.7	170.5	123.4	-280.6	-715.8	207.5	-246.3	-485.3	-718.4	-92.8	-655	-218	-246.9	349.8	110.8	-153.8	7.7	149.9	142.6	119.3	32.3	23.9	45.2	-29

利润表行

Northeast Pharmaceutical Group Co., Ltd. 的收入与上期相比变化了 -0.074%。据报告, 000597.SZ 的毛利润为 3140.22。该公司的营业费用为 2773.84，与上年相比变化了 -6.838%. 折旧和摊销费用为 575.08，与上一会计期间相比变化了 0.025%. 营业费用报告为 2773.84，显示-6.838% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.003%. 营业收入为 366.37，与上年相比变化了-0.003%. 净利润的变化率为 0.023%。去年的净收入为358.46.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
income-statement-row.row.total-revenue	7791.84	8161.4	8808.9	8145.1	7384.4	8220.1	7466.6	5676.4	4814.4	3834.4	4333.3	3870.6	3864.9	3882.8	4828.7	5093.6	4609.8	3706.1	1918.2	1833.1	1619.7	1606.9	1397	1442	1197.6	1011.5	760.6	757.5	1166.1	1049.7	934.6	1001.8
income-statement-row.row.cost-of-revenue	4811.3	5021.2	5377.4	4928.9	4492.7	4638	4377.2	3431.8	3295.1	2817.1	2967.1	2675.8	2908.4	3090.2	3697.8	3535.9	3031.5	2983.7	1497.6	1410.6	1243.7	1227.2	1111.5	1131.8	897.6	734.7	560.4	608.2	1018.2	891.2	716.6	727.1
income-statement-row.row.gross-profit	2980.54	3140.2	3431.5	3216.2	2891.7	3582.1	3089.4	2244.6	1519.3	1017.3	1366.3	1194.8	956.5	792.6	1130.9	1557.7	1578.2	722.4	420.6	422.5	376	379.7	285.5	310.2	300	276.8	200.2	149.2	147.9	158.5	218	274.8
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	98.77	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	167.44	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	1611.42	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-110.08	-188.1	498.2	452.3	442	584.9	137.8	-12.4	43.4	26.5	112.6	44.6	377.3	89	98.7	72	5.4	31.5	8.4	-11.4	-4	0.9	-0.7	-4.5	1.9	23.1	15	-72.4	-0.1	12.4	10	4.8
income-statement-row.row.operating-expenses	2472.45	2773.8	2977.5	2859.9	2565.8	3134.2	2617.7	1878.8	1323.7	1214.1	1182	1227.7	1117	1103.2	951.2	905	723.7	452.8	344.6	341.9	301.2	315	212.4	212	214.3	181.1	86	93.1	115.8	93.8	108.3	181.2
income-statement-row.row.cost-and-expenses	7283.75	7795.1	8354.8	7788.8	7058.4	7772.2	6994.9	5310.6	4618.8	4031.3	4149	3903.5	4025.4	4193.4	4649.1	4440.9	3755.2	3436.5	1842.3	1752.5	1544.9	1542.1	1323.9	1343.8	1111.9	915.8	646.4	701.3	1134	985	824.8	908.3
income-statement-row.row.interest-income	167.26	155.1	93.9	55.9	58.4	26.3	31	17.8	28	22.1	26.4	14.4	9.9	12.1	12.5	11.6	5.4	3.5	4.1	4.6	5.5	4.9	2.7	2	9.2	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	76.68	78.4	92.1	120.2	120.9	125.6	154.6	161.7	146.1	153.6	166.1	162.6	141.6	114.4	118.9	97.3	111.1	70.1	39.4	37.9	47.1	64.7	77.3	78.8	66	72.9	70.4	65.5	13.9	26.9	47.3	45.8
income-statement-row.row.selling-and-marketing-expenses	1611.42	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	35.92	121.8	158.1	-228.2	-187.2	-265.1	-258	-263.6	-158.2	-210	-78.5	-126.1	203	-70.7	-102.5	-68.3	-354.9	-137.6	-38.8	-39.1	-40.5	-65.7	-75	-76.2	-52.2	-66.9	-45.9	-135.3	-10.3	-8.2	-43.9	-39.1
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-110.08	-188.1	498.2	452.3	442	584.9	137.8	-12.4	43.4	26.5	112.6	44.6	377.3	89	98.7	72	5.4	31.5	8.4	-11.4	-4	0.9	-0.7	-4.5	1.9	23.1	15	-72.4	-0.1	12.4	10	4.8
income-statement-row.row.total-operating-expenses	35.92	121.8	158.1	-228.2	-187.2	-265.1	-258	-263.6	-158.2	-210	-78.5	-126.1	203	-70.7	-102.5	-68.3	-354.9	-137.6	-38.8	-39.1	-40.5	-65.7	-75	-76.2	-52.2	-66.9	-45.9	-135.3	-10.3	-8.2	-43.9	-39.1
income-statement-row.row.interest-expense	76.68	78.4	92.1	120.2	120.9	125.6	154.6	161.7	146.1	153.6	166.1	162.6	141.6	114.4	118.9	97.3	111.1	70.1	39.4	37.9	47.1	64.7	77.3	78.8	66	72.9	70.4	65.5	13.9	26.9	47.3	45.8
income-statement-row.row.depreciation-and-amortization	354.3	575.1	561.1	550.9	480.8	340.4	323	326.3	317.3	213	171.3	147.7	158.9	217.8	190.2	128	105.3	101.7	80.2	85.6	62.4	66.5	51.1	44.1	36.3	36.2	42.5	43.1	6.5	15.3	37.4	46.1
income-statement-row.row.ebitda-caps	808.58	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	454.28	366.4	367.4	348.3	279	489.3	76	114.5	1.6	-403.2	7.1	-202.9	-332.4	-469.6	37.9	532.4	495	102	51.7	48.9	30.6	8.4	14.4	25.6	37.7	48.9	77.9	13	25.5	49.4	72.4	47.5
income-statement-row.row.income-before-tax	490.21	488.2	525.4	120.2	91.8	224.2	213.7	102.2	37.4	-406.9	105.7	-159	42.5	-381.2	77.1	584.4	499.7	131.9	48.6	39.5	30.5	4.1	5.9	21.6	36.6	50.4	80.6	-69.2	23.6	59.1	74.1	53.4
income-statement-row.row.income-tax-expense	127.72	112.2	168.4	24.7	81	53.8	12.4	10.1	11.1	-14.7	21.9	6.2	37	0.2	23.3	108.3	141.7	84.9	29	26.1	22.3	8.8	-4.2	11.5	7.8	7	12.4	-53	3.6	12	10.9	9.4
income-statement-row.row.net-income	346.04	358.5	350.3	99	12.3	174	195.2	119	23.8	-384.4	87.1	-167	8.1	-390	50	476.1	357.9	47.5	19.6	13.4	8.1	8.7	10.2	10.1	28.9	43.4	68.2	-69.2	19.9	47.1	63.2	44